Abstract
Medicinal products of nootropic action, which have a positive effect on neurometabolism and normalize memory and intellectual functions, are an important component of complex pharmacotherapy for various neurological and cerebrovascular diseases. The aim of the work was an experimental study of the nootropic activity of the new combined drug Melarginin, which includes 3-(2,2,2-trimethylhydrazinium) propionate (meldonium), L-arginine, and inosine in a fixed ratio.
In experiments on female Balb/c mice, it was established that Melarginin in doses of 250 and 500 mg/kg (per os for 14 days) statistically significantly increased the survival of animals in acute hypoxia, in a dose of 250 mg/kg - contributed to the preservation of cognitive function in experimental amnesia, improved spatial memory and recognition of the new location of the object, and in a dose of 500 mg/kg - increased muscle tone and endurance to physical and psychoemotional stress. The revealed effects indicate a nootropic effect due to the combined cyto- and cerebroprotective properties of the studied combined agent components. Based on the obtained data, the new pharmacological combination can be a promising drug for neurological recovery and improvement of physical and mental performance in chronic cerebrovascular pathology.
Keywords: combined drug Melarginin, hypoxia, amnesia, nootropic activity.
Publisher
State Institution - D. F. Chebotarev Institute of Gerontology NAMS of Ukraine
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science
Reference47 articles.
1. Boldyrev, A. A. Oxidative stress and the brain. Soros Educational Journal 2001, 7, 21–27. (in Russian)
2. Lukyanova, L. D. Molecular mechanisms of tissue hypoxia and body adaptation. Physiol. Journal 2003, 49, 3, 17–35. (in Russian)
3. Clemens, J. A. Cerebral ischemia gene activation, neuronal injury, and the protective role of antioxidants. Free Radic Biol Med 2000, 28, 10, 1526–1531. https://doi.org/10.1016/s0891-5849(00)00258-6
4. Kontos, H. Oxygen Radical in Cerebral ischemia: The2001Willis ture. Stroke 2001, 32, 2712–2716. https://doi.org/10.1161/hs1101.098653
5. Morris, G.; Maes, M. Mitochondrial dysfunctions in myalgic encephalomyelitis/ chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metabolic brain disease 2014, 29, 1, 19-36. https://doi.org/10.1007/s11011-013-9435-x